A Case of Antithyroid Drug-Induced Agranulocytosis Pre-Covid 19 Era
No Thumbnail Available
Date
2020
Journal Title
Journal ISSN
Volume Title
Publisher
جامعة الشيخ عبدالله البدري
Abstract
Agranulocytosis is an infrequent and serious side effect of antithyroid drugs characterized by a noticeable reduction
in granulocyte and neutrophil count, it usually occurs within the first 2-3 months of treatment. There is a variety
of mechanisms by which ATD can induce agranulocytosis, direct drug effects, and immunological mechanisms.
We present 33 years old female attended Atbara teaching hospital who has developed agranulocytosis 2 weeks
after starting ATD to treat relapsed Graves’ disease. What was unusual about this patient is that symptoms have
occurred in a period less than 15 days of starting treatment and with a dose of 45 mg/day. The physician must
educate the patient about the possibility of early onset of serious side effects of ATD and to seek medical advice
as soon as possible